BMP1 and digestive system neoplasm: It is noteworthy that, while previous studies tested BMP1 inhibitors in the animal models of skin29,30, kidney31,32 and liver fibrosis33, the anti-fibrotic efficacy of BMP1 inhibitors in lung fibrosis models has not been documented.